News

January 27, 2021

WASHINGTON—Covington is advising Veritas Capital on the acquisition of Perspecta Inc. by Veritas portfolio company Peraton for $7.1 billion. The transaction is expected to close in the first half of 2021. Following closing, Perspecta will be combined with Peraton, a trusted provider of highly differentiated space, intelligence, cyber, defense, homeland security ...

January 26, 2021

WASHINGTON—The Deal named Catherine Dargan and Amy Wollensack among the “Top Women in Dealmaking” in its publication, The Dealmaker Quarterly. Comprising the top women in dealmaking as nominated by their peers, this year’s list identifies women who have displayed excellence in their respective legal fields including mergers and acquisitions, private equity, ...

January 26, 2021

LOS ANGELES—The Los Angeles Business Journal has named Ali Mojibi and Neema Sahni to its ”Minority Leaders of Influence: Attorneys” list, a recognition of leading minority Los Angeles-based lawyers. Mr. Mojibi is a partner in Covington’s Los Angeles office. He serves as trial counsel for Fortune 500 and leading emerging companies, with a focus on patent, trade ...

January 25, 2021

LONDON–Covington’s London corporate team has advised AIM- and Main Market-listed clients on multiple fundraisings and acquisitions over the past few months, marking a strong year in life sciences transactions. These include: Advising Sensyne Health plc, a UK clinical AI company listed on the London AIM market, on its £27.5 million equity fundraising The ...

January 25, 2021

LONDON—Covington advised Nasdaq-listed Oxford Immunotec Global PLC in its agreement to be acquired by PerkinElmer, Inc., in a deal valued at approximately $591 million. Under the terms of the acquisition, Oxford Immunotec shareholders will be entitled to receive $22.00 in cash for each outstanding ordinary share. The terms of the acquisition value Oxford ...